Summary of clinical experience with recombinant factor VIII products--Kogenate.
Lusher
J M
JM
Department of Pediatrics, Hematology/Oncology Division, Children's Hospital of Michigan, Detroit 48201.
D016063:Blood Loss, Surgical / Q000517:prevention & control*; D005169:Factor VIII / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000633:toxicity*; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity
D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII